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Coronary angiographyAbstract Background: The clinical implication of insulin resistance has extended beyond diabetes
mellitus to include ischemic heart disease, dyslipidemia, hypertension and features of metabolic syn-
drome. Non diabetic patients with acute coronary syndrome and elevated admission insulin resis-
tance index (AIRI) may have certain clinical angiographic and therapeutic strategies.
Objectives: It was aimed to illustrate the value of AIRI in non diabetic patients with acute coronary
syndrome (ACS) and identify the angiographic CAD severity in relation to AIRI.
Study design: Cross sectional study.
Patients and methods: Includes 120 non diabetic patients presenting with acute chest pain who were
admitted to the Coronary Care Unit. Admission glucose and insulin concentration were measured
and the AIRI were calculated. ECG was carried out and the cases were grouped as; unstable angina
(UA) (40 cases) and acute myocardial infarction (AMI) (40 cases). They were compared to 40 cases
of the stable angina (SA) group and the control group (40 cases). The studied cases were examined
clinically stressing on the other criteria of insulin resistance syndrome. The following laboratory
tests were undertaken including random plasma glucose, HBA1-c, lipid proﬁle, cardiac enzymes
(CK-MB, LDH, troponin T). The angiographic study was carried out for patients of each diseased
group and 20 cases of the stable angina group.
Results: AIRI was signiﬁcantly elevated in AMI (3.9 ± 0.1) and UA (3.01 ± 0.2) when compared
to the group of SA and the control group. AIRI was signiﬁcantly higher in AMI when compared to
the UA group. Coronary angiography revealed one coronary vessel involvement in 10%, 20%, and
302 W. Refaie, A. Elewa10% of SA, UA and AMI, respectively. While, two vessel involvement was detected in 0%, 30%,
and 60% of SA, UA and AMI, respectively. Three coronary vessel disease was not detected in SA
but was evident in 5% of UA and 30% of AMI. The relation of AIRI of the studied groups by the
calculated Chi-square revealed a signiﬁcant elevation of AIRI in AMI and UA. Cases with three
vessel affection demonstrated higher AIRI.
Conclusion: Elevated AIRI can predict coronary artery events in non diabetic patients with acute
chest pain. Multiple coronary vessel involvement is common in such cases and suitable planned
invasive therapeutic strategies have to be considered.
ª 2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Cardiology.1. Introduction
IR is one of the most important public health problems of the
twenty ﬁrst century1 and the interest in identifying clinical syn-
dromes of IR background has increased since the availability of
insulin sensitizer agents.2 It is now considered the basic etio-
pathogenetic factor for coronary artery disease (CAD), hyper-
tension (HTN), dyslipidemia and endothelial dysfunction.3
In response to IR, compensatory hyperinsulinemia takes
place in a trial to prevent the onset of type 2 diabetes mellitus
(DM), though potentially predisposing to many cardiovascular
diseases (CVD), essential HTN, fatty liver disease and sleep
apnea syndrome.4
Clavijo et al.5 concluded that IR in non diabetic patients
with AMI is associated with larger infarct size and more hos-
pital complications.
Sinha and coworkers6 concluded that HOMA-IR measure-
ment on patients admitted with myocardial infarction (MI)
provides an important predictor measure of poor outcome
and is superior to admission glucose measurement. Admission
insulin resistance index (AIRI) is a method for measuring IR
(Admission serum insulin lIU/ml · Admission plasma glucose
mmol/L/22.5).7 AIRI is derived in the same way as the fasting
insulin resistance (FIRI) which correlates signiﬁcantly with the
Homeostasis Model Assessment (HOMA) of IR based on fast-
ing plasma glucose and insulin concentrations.8
Although it has been previously reported that patients
admitted with IR carry a poor prognosis in coronary events9,10
yet the predictive effect of the degree of IR with its multiple
confounding variables on the extent of CAD affection needs
more conﬁrmation.
1.1. Aims
It was aimed to illustrate the value of AIRI in non diabetic pa-
tients with acute coronary syndrome, investigate the relation-
ship of AIRI with other CV risk factors and components of
metabolic syndrome and identify the angiographic CAD sever-
ity in relation to AIRI.2. Design
Cross-sectional study.
3. Subjects and methods
Eighty non diabetic patients with ACS, were compared to 40
patients with stable angina and 40 control individuals. Thecases presented with acute chest pain underwent clinical exam-
ination, ECG and were admitted to the Cardiology Care Unit,
Mansoura Specialized Hospital in the period from January
2010 to January 2011. AIRI was calculated (Plasma glucose
mmol/L · plasma insulin lIU/22.5). The studied cases were
examined clinically stressing on the other criteria of IRS
including BMI, waist circumference and mean arterial blood
pressure. The following laboratory tests were undertaken
including random plasma glucose, HBA1-c, lipid proﬁle (ser-
um triglyceride, cholesterol, LDL ch, HDL-ch), cardiac en-
zymes (CK-MB, LDH, troponin T) liver, and kidney
function tests. The study protocol was approved by the cardi-
ology ethics committee and informed consents were obtained.
The cases were classiﬁed into four groups
 Group 1: Stable angina (40 cases)
 Group 2: Unstable angina (40 cases)
 Group 3: Acute myocardial infarction (40 cases)
 Group 4: This group included 40 control volunteers of
matched age and sex.3.1. Exclusion criteria
Known diabetics, smokers, thyroid disorders, muscular dis-
ease, clinically evident renal or hepatic disease.
Angiographic studies were undertaken for each diseased
group and 20 cases of the stable angina group and were taken
at random. The extent of CAD was measured according to the
number of major coronary arteries affected by CAD (Arslan
et al.).11 CAD was deﬁned as stenosis of at least 50% in at least
one major coronary artery.11 The extent of CAD lesions was
quantiﬁed using the number of vessels with P50% stenosis.
Management of coronary artery lesions was individually under-
taken by coronary stent or CABG. Thrombolytic therapy was
not tried as the cases presented >12 h of the onset of chest pain.
4. Statistical analysis
Statistical analysis was performed by using the statistical pack-
age for social science program (SPSS) version ‘‘16’’. The qual-
itative data were presented as frequency and percentages. The
quantitative data were examined by using the Kalmogrov–
Smirnov test to test for normal distribution of the data and
when parametric, expressed as mean and standard deviation.
Student’s t test was used, to test for difference in normally dis-
tributed quantitative data between the two groups. The Mann–
Whitney-l test was used for comparison between two groups
when data are not normally distributed. Signiﬁcance was con-
sidered when p value is less than 0.05.
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Admission insulin resistance index in non diabetic patients 3035. Results
The examined cases were 120 patients (40 cases SA, 40 cases
UA, and 40 cases AMI) who were compared to 40 control
cases of matched age and sex.
The age of the studied cases ranged from 49.7 ± 3.6 to
53.9 ± 1.1 years, being signiﬁcantly higher in the infarcted
group and the unstable angina group. There were no signiﬁ-
cant differences between the SA group and the control group.
BMI was 30.1 ± 1.5 in UA and 30.4 ± 1.9 in AMI group
being signiﬁcantly higher when compared to the reference
and SA groups. No signiﬁcant differences between the UA
group and the AMI group were detected.
Waist circumference was signiﬁcantly larger in the UA and
the AMI when compared to the SA and the reference group.
But an insigniﬁcant difference between the two groups of
ACS was observed.
The MABP was signiﬁcantly increased in both UA and
AMI when compared to SA and/or the control group.
The biochemical changes; S. cholesterol, TG, HDL C, LDL
C, HbA1-c were insigniﬁcantly different among the studied
groups. Random plasma glucose and plasma insulin were sig-
niﬁcantly higher in the UA and AMI groups when compared
to the reference and SA groups. There was an insigniﬁcant dif-
ference on comparing the SA group with the control group.
The AIRI was signiﬁcantly higher in the UA and AMI
groups when compared to the reference and SA groups
(p< 0.001). However patients with AMI revealed signiﬁcantly
higher AIRI when compared to the UA group (p< 0.02).
There was an insigniﬁcant difference on comparing the SA
group with the control group.
Coronary angiography was performed in all cases of UA
and the AMI groups and in 20 cases of the SA group being
their ﬁrst attack. Signiﬁcant coronary artery disease was con-
sidered when the narrowed CA was P50% and the number
of vessels and degree of narrowing were estimated. One coro-
nary vessel affection was detected in 10%, 20%, and 10% of
AMI, UA and SA group, respectively. Two vessel disease
was observed in 60% of AMI, 30% of UA and 0% of SA.
Three vessel disease was recorded in 30% of AMI and 5%
of UA and was not detected in SA (Table 2). Insigniﬁcant nar-
rowing of coronary vessels was detected in 45% of UA cases,
while it was not detected in AMI.
The AIRI (Table 1) was highest (3.9 ± 0.1) in AMI while it
was 3.01 ± 0.2 in UA and 1.5 ± 0.13 in SA. The calculated
Chi-square showed that higher the AIRI, more severe is the
state of myocardial ischemia. (Table 3) The frequency of ele-
vated AIRI was higher most with AMI followed by UA and
lowest in those with stable angina (Table 3). The number of
coronary vessels was signiﬁcantly higher (three vessels) with
higher AIRI (Table 4).
6. Discussion
Caccamo et al.12 reported that IR quantiﬁed by the HOMA in-
dex is considered the ‘‘premuim movens’’ for the development
of metabolic syndrome (MS).
IR was reported to predict CVD independently of other
risk factors. Stubbs et al.7 concluded that AIRI is of great va-
lue in identifying IR state in non diabetics with ACS. In the
present study many components of MS revealed insigniﬁcant
Table 2 Frequency of coronary arteries’ affection in the studied groups.
SA Group (1)
20 cases
UA Group (2)
40 cases
AMI Group (3)
40 cases
P1–2 P1–3 P2–3
no% no% no%
One coronary vessel signiﬁcant stenosis 2/20 10% 8/40 20% 4/40 10% 0.331 1 0.210
Two coronary vessel signiﬁcant stenosis 0/20 0% 12/40 30% 24/40 60% 0.006 <0.001 0.007
Three coronary vessel signiﬁcant stenosis 0/20 0% 2/40 5% 12/40 30% 0.313 0.006 0.003
One coronary vessel insigniﬁcant narrowing 18/20 90% 18/40 45% 0/40 0% <0.001 <0.001 <0.001
Table 3 Calculated Chi- square of AIRI in the studied groups.
SA Group (1)
(40 cases)
UA Group (2)
(40 cases)
AMI Group (3)
(40 cases)
Control Group (4)
(40 cases)
P1–2 P1–3 P1–4 P2–3 P2–4 P3–4
No of cases with
normal AIRI
36 16 8 40 <0.001 <0.001 0.041 0.052 <0.001 <0.001
No of cases with
elevated AIRI
4 24 32 0 <0.001 <0.001 0.041 0.052 <0.001 <0.001
Table 4 Relation of number of vessels affected to AIRI.
One CV aﬀection 1 (12 cases) Two CV aﬀection 2 (36 cases) Three CV aﬀection 3 (14 cases) P1–2 P1–3 P2–3
AIRI 1.7 ± 0.1 3.3 ± 0.1 3.8 ± 0.8 <0.001 <0.001 0.023
304 W. Refaie, A. Elewachanges on comparing the different groups. Esam et al.13
found insigniﬁcant correlation between AIRI, MABP, TG,
HDL-C and serum cholesterol.
In the present study risk factors for coronary atherosclero-
sis were evident. These factors are among the criteria for diag-
nosing MS according to the National Cholesterol Education
Program and the Adult Treatment Panel III (NCEP-ATP III
2001)14 (Table 1).
Caccamo and colleagues12 concluded that IR detected by
HOMA has an important prognostic role with worst prog-
nosis. Clavijo et al.5 also reported that IR in AMI is asso-
ciated with larger infarct size, more complications of
AMI and an increase in acute renal failure. In the present
study the AMI group has more signiﬁcant elevation of
CK-MB in relation to the control, SA and UA groups
(Table 1).
In the present study the age was signiﬁcantly increased in
the AMI group compared to the control, SA and UA groups.
Increased aging with increased visceral fat is associated with
more IR.15
The insigniﬁcant elevation in mean arterial BP observed in
the AMI group compared to the stable angina group in the
present work is not in agreement with previous reports.16,17
But can be explained by McFarlane et al.16 and Michinori17
who suggest it to be secondary to the sympathetic nervous sys-
tem activation by stress of admission, salt and water retention
effects of hyperinsulinemia and renin angiotensin system
stimulation.
The signiﬁcant increase in BMI and WC in the ACS group
and the stable angina group in comparison to the control
group is usually associated with decreased insulin sensitivity
in peripheral tissues, reduced ability of insulin to suppress he-patic glucose production and stimulation of glucose disposal in
peripheral tissues. Campbell and Gerich,18 found that euglyce-
mia is inversely correlated with BMI.
The insigniﬁcant increase in serum cholesterol, serum TG
and serum LDL-C and the insigniﬁcant decrease in HDL-C
in the AMI and the UA group compared to the control group
are in accordance with Reaven et al.,19 who discussed coronary
heart disease in the absence of hypercholesterolemia.
The signiﬁcant high elevation in AIRI in the ACS is in
agreement with the results of Stubbs et al.7 who found that
AIRI is a simple measure of insulin resistance that correlated
well with other insulin resistance indices. This simple measur-
ing of an admission IRI makes it suitable for large scale
studies.7
In the present study, all cases from each of ACS and 20
cases of the ﬁrst attack of the stable angina group underwent
coronary angiography. The extent of CAD was quantiﬁed
using the number of vessels with more than 50% stenosis.11
Shin Eui Yoon et al.10 assessed the value of IR scores in rela-
tion to angiographic CAD severity.
Sinha and coworkers6 concluded that HOMA-IR measure-
ment on patients admitted with AMI provides an important
predictor measure of poor outcome and is superior to admis-
sion glucose measurement. The present study revealed that
higher the AIRI more the coronary vessel affection. This is
in accordance with Shin Eui Yoon et al.10 who found a higher
prevalence of multiple vessel CAD in patients with higher
AIRI.
Signiﬁcant angiocardiographic ﬁndings of multivessel coro-
nary artery disease in relation to elevated AIRI may help to
identify patients who could beneﬁt from alternative early inva-
sive strategies.6
Admission insulin resistance index in non diabetic patients 305Cardiac myocytes in patients with CAD have resistance to
insulin mediated glucose disposal.20 This may expose the car-
diac myocytes to double jeopardy, not only to rapid depletion
of low glycogen stores but to impaired glucose delivery to
ischemia myocardium as well, by the IR mediated glucose dis-
posal. The DIGAMI study examined effects of metabolic
support using glucose–insulin–potassium (GIK) infusion and
subsequent insulin in diabetic patients sustaining a myocardial
infarct and reported better prognosis.21
Kragelund and associates9 reported that although AMI in-
duces a transient decline in insulin secretion induced by an in-
crease in the activity of the sympathoadrenal system, the high
insulin level in the present study is most likely a measure of se-
vere IR prior to myocardial infarction.
7. Conclusion
AIRI is a simple measure to identify IR states. The presence of
IR in ACS may have a role in identifying the extent of coro-
nary vessel affection in non diabetic patients, and suitable
planned invasive therapeutic strategies have to be considered.
Further studies are needed to clarify the signiﬁcance of the
other component of insulin resistance syndrome as BMI and
waist circumference in patients with acute coronary syndrome.
References
1. Miller AM, Alcaraz Ruiz A, Borrayo Sa´nchez G, et al. Metabolic
syndrome: clinical and angiographic impact on patients with acute
coronary syndrome. Cir Cir 2010;78(2):113–20.
2. Stern SE, Williams K, Ferrannini E, et al. Identiﬁcation of
individuals with insulin resistance using routine clinical measure-
ments diabetes 2005;54:333–9.
3. Stuhlinger MC, Abbasi F, Chu JW. Relationship between insulin
resistance and an endogenous nitric oxide synthase inhibitor.
JAMA 2002;287:1420–526.
4. Reaven GM. Role of insulin resistance in human disease. Diabetes
1988;37:1595–607.
5. Clavijo LC, Pinto TL, Kuchulakanti PK, et al. Metabolic
syndrome in patients with acute myocardial infarction is associ-
ated with increased infarct size and in-hospital complications.
Cardiovasc Revasc Med 2006;7(1):7–11.
6. Sinha DP, Ahmed S, Baneerjee AK, et al. Signiﬁcance of an index
of insulin resistance in non-diabetic patients with impaired fasting
glucose with acute myocardial infarction and its correlation to
short term outcome. Indian Heart J 2009;61(1):40–3.7. Stubbs PJ, Alaghband-Zadeh J, Laycock JF, et al. Signiﬁcance of
an index of insulin resistance on admission in non-diabetic patients
with acute coronary syndromes. Heart 1999;82(4):443–7.
8. Matthews DR, Hosker JP, Rudenski JS, et al. Homeostasis model
assessment: insulin resistance and aˆ-cell function from fasting
plasma glucose and insulin concentrations in man. Diabetologia
1985;28:412–9.
9. Kragelund C, Snorgaard O, Kober L. Hyperinsulinaemia is
associated with increased long term mortality following acute
myocardial infarction in non-diabetic patients. Eur Heart J
2004;25:1891–7.
10. Yoon Shin-Eui, Ahn Sung Gyun, Kim Jang-Young, et al.
Differential relationship between metabolic syndrome score and
severity of coronary atherosclerosis as assessed by angiography in
a non-diabetic and diabetic Korean population. J Korean Med Sci
2011;26:900–5.
11. Arslan U, Tu¨rkog˘lu S, Balciog˘lu S, et al. Association between
nonalcoholic fatty liver disease and coronary artery disease. Coron
Artery Dis 2007;18(6):433–6.
12. Caccamo G, Bonura F, Vitale G, et al. Insulin resistance and
acute coronary syndrome. Atherosclerosis 2010;211(2):672–5 Epub
2010 Apr 4.
13. Esam N, Mohamed A, Ghonemy A, et al. Value of admission
insulin resistance index application to non-diabetics with acute
coronary syndromes, 15 th Zagazig Annual Medical Conference.
Zagazig Univ Med J 2007;11:104–16.
14. Executive Summary of the Third Report of The National
Cholesterol Education Program (NCEP) Expert Panel on Detec-
tion, Evaluation, and Treatment of High Blood Cholesterol in
Adults (Adult Treatment Panel III). JAMA 2001; 285:2486.
15. Cefalu WT, Wang ZQ, Werbel S. Contribution of visceral fat mass
to insulin resistance of aging. Metabolism 1995;44:954–9.
16. Mc Farlane IS, Maryann B, Sowers JR. Insulin resistance and
cardiovascular disease. J Clin Endocrinol Metabol 2001;86:713–8.
17. Michinori I. Hypertension and insulin disorders. Curr Hypertens
Rep 2002;4:477–82.
18. Campbell PJ, Gerich JE. Impact of obesity on insulin action in
volunteers with normal glucose tolerance: demonstration of the
threshold for adverse effect of obesity. J Clin Endocrinol Metabol
1993;6:70–1114.
19. Reaven GM, Bernstein R, Davis B. Coronary heart disease in the
absence of hypercholesterolaemia. J Intern Med 2000;236:415–7.
20. Reaven GM. Role of insulin resistance in human disease
(syndrome X): an expanded deﬁnition. Annu Rev Med
1993;44:121–31.
21. Malmberg K, Ryden L, Efendic S, et al. Randomized trial of
insulin-glucose infusion followed by subcutaneous insulin treat-
ment in diabetic patients with acute myocardial infarction
(DIGAMI study): effects on mortality at 1 year. J Am Coll
Cardiol 1995;26:57–65.
